Apollo Hospitals Enterprise is currently trading at Rs. 7437.30, up by 72.20 points or 0.98% from its previous closing of Rs. 7365.10 on the BSE.
The scrip opened at Rs. 7393.95 and has touched a high and low of Rs. 7438.55 and Rs. 7341.15 respectively. So far 2649 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 7634.45 on 08-Jul-2025 and a 52 week low of Rs. 6002.15 on 28-Feb-2025.
Last one week high and low of the scrip stood at Rs. 7484.20 and Rs. 7220.00 respectively. The current market cap of the company is Rs. 106889.51 crore.
The promoters holding in the company stood at 29.34%, while Institutions and Non-Institutions held 65.06% and 5.61% respectively.
Apollo Hospitals Enterprise and Siemens Healthineers have joined hands for a research collaboration to advance innovation in liver healthcare. The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes from early detection and risk stratification to monitoring intervention and therapy response. AI-driven disease progression models shall play a pivotal role in early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: